Biocon Limited has partnered with Tabuk Pharmaceuticals to commercialize its GLP-1 products for diabetes and weight management in the Middle East, with plans for further product expansion and possible local manufacturing in the future.
AI Assistant
Biocon Ltd
2024
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.